top of page
uBriGene Resources
uBriGene’s global expertise and infrastructure in Advanced Therapy Medicinal Products (ATMPs) offer comprehensive support from product development through GMP production and regulatory processes. Our robust platform advances your therapies from concept to commercialization, ensuring high-quality outcomes and faster market entry.
We excel in cell therapies (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA-based medicines (mRNA, circRNA, acRNA). Our focus is on enhancing product yields, reducing lead times, and cutting costs while providing full support in manufacturing, quality control, and regulatory filings.
bottom of page